Decision-tree approach to the immunophenotype-based prognosis of the B- cell chronic lymphocytic leukemia

American Journal of Hematology

Volumn 59, Issue 2, 1998, Pages 143-148

  Mašić, Nikola ^a   Gagro, Alenka ^b   Rabatić, Sabina ^b   Sabioncello, Ante ^b   Dašić, Gorana ^b   Jakšić, Branimir ^c   Vitale, Branko ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b INSTITUTE OF IMMUNOLOGY   (Croatia)

^c University of Zagreb   (Croatia)

Author keywords

B CLL; Decision tree analysis; Prognosis; sCD23; T and B cell immunophenotyping

Indexed keywords

CD23 ANTIGEN;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER STAGING; CELL DEATH; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DECISION THEORY; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOPHENOTYPING; MALE; MEDICAL DECISION MAKING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; DECISION MAKING, COMPUTER-ASSISTED; DECISION TREES; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, IGE;

EID: 0031665018     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199810)59:2<143::AID-AJH7>3.0.CO;2-Y     Document Type: Article

References (21)

1. Foon KA, Rai KR, Gale RP: Chronic lymphocytic leukemia: New insights into biology and therapy. Ann Intern Med 113:529-539, 1990.
2. Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Bold DH, Kempin SJ: Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute sponsored working group. Am J Hematol 29:152-163, 1988.
3. Rai KR: A critical analysis of staging in CLL. In: Gale RP, Rai KR, eds. Chronic Lymphocytic Leukemia: Recent Progress and Future Directions. New York: Alan R. Liss, 1987, pp 252-264.
4. Rabatić S, Gagro A, Medar-Lasić M: CD21-CD23 ligand pair expression in children with allergic asthma. Clin Exp Immunol 94:337-340, 1993.
5. Quinlan JR: C4.5: Programs for Machine Learning. San Francisco: Morgan Kaufman Publishers, 1993.
6. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Cuault MT, Monconduit M, Belabbes S, Gremy F: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198-206, 1981.
7. International Workshop on CLL: Chronic lymphocytic leukaemia: Proposal for a revised prognostic system. Br J Haematol 48:365-367, 1981.
8. Jakšić B, Vitale B: Total tumor mass score (TTM): A new parameter in chronic lymphocytic leukaemia. Br J Haematol 49:405-413, 1981.
9. Vitale B, Kušić B, Antica M, Poljak LJ, Gagro A, Rabatić S, Jakšić B: Chronic lymphocytic leukemia (CLL): A paradigm for developmental imbalance in B-cell and T-cell communication. Period Biol 97:273-280, 1995.
10. Caligaris-Cappio F: B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 87:2615-2620, 1996.
11. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plesner T, Thorling K, Andersen E, Andersen PK: Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 78: 1795-1802, 1991.
12. Dadmarz R, Cawley JC: Heterogeneity of CLL: High CD23 antigen and α-IFN receptor expression are features of favorable disease and of cell activation. Br J Haematol 68:279-282, 1989.
13. Barnett D, Reilly JT: Lack of correlation between cell surface activation antigen expression and clinical stage in B-CLL. Br J Haematol 73:572, 1989.
14. Gibson J, Neville S, Joshua D, Kroninberg H: CD23 antigen expres-sion in CLL. Br J Haematol 72:598, 1989.
15. Newman RA, Peterson B, Davey FR, Brabyn C, Collins H, Brunetto VL, Duggan D, Weiss RB, Royston I, Millard FE, Miller AA, Bloomfield CD: Phenotypic markers and bcl-1 gene rearrangements in B-cell chronic lymphocytic leukemia: A Cancer and Leukemia Group B Study. Blood 82:1239-1245, 1993.
16. Reinisch W, Willheim M, Hilgarth M, Gasche C, Mader R, Szepfalusi S, Steger G, Berger R, Lechner K, Boltz-Nitulescu G, Schwartzmeier JD: Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. J Clin Oncol 12:2146-2152, 1994.
17. Fournier S, Rubio M, Delespesse G, Sarfati M: Role of low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 84:1881-1886, 1984.
18. Bonnefoy JY, Lecoanet-Henchoz S, Aubry JP, Gaushat JF, Graber P: CD23 and B-cell activation. Curr Opin Immunol 7:355-359, 1995.
19. + T-helper cells after activation in vitro. Immunology 76: 103-109, 1992.
20. + T-cells immunoregulate spontaneous in vitro immunoglobulin production by normal and chronic lymphocytic leukaemia B-cells. Leuk Lymphoma 18:103-111, 1995.
21. + T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood 88:3513-3521, 1996.